Eight Advisory supported Sanofi in its acquisition of Inhibrx

Eight Advisory supported Sanofi in its acquisition of Inhibrx

Eight Advisory provided financial due diligence services to Sanofi in support of its acquisition of Inhibrx, Inc. This transaction is in line with Sanofi's strategy to expand its portfolio to address unmet medical needs of patients.

Sanofi, an innovation-driven global healthcare company, provides life-changing therapeutic solutions for patients. The addition of the INBRX-101 asset for the treatment of alpha-1 antitrypsin deficiency, a disease that primarily affects the lungs and leads to progressive tissue degradation, underlines the Group’s strategy to develop distinctive products.

 

Inhibrx is a publicly traded clinical-stage biopharmaceutical company specialising in the development of a broad portfolio of new biologic drug candidates. The company utilises a variety of protein engineering methodologies to address the specific needs of complex targets and diseases, including its proprietary protein engineering platforms.

 

Under the terms of the merger agreement, Sanofi will acquire all outstanding shares of Inhibrx for $30.0 per share in cash, representing an equity value of approximately $1.7 billion (on a fully diluted basis).

 

We are pleased to have supported Sanofi in the financial due diligence review of this listed target company,” says Katia Wagner, Partner at Eight Advisory.

 

Eight Advisory team members supporting on this transaction :

Financial Due Diligence: Katia Wagner, Partner, Laurent Williot, Partner, Louis Legros, Director, and Guillaume Heral, Manager.

Katia

Wagner

Partner

Transaction Services

Eight Advisory Paris

Laurent

Williot

Partner

M&A Transaction Services, Energy & Infrastructure

Your message has been sent
Thank you, your application has been sent.

Report request

Similar
Articles

Deals

Eight Advisory team assisted Gedeon Richter in their investment in Mithra assets Estetra and Neuralis

12 Jun 2024

Read more

Financial Restructuring

Insights

Weapon financing: Small and medium-sized enterprises suffer particularly from bank reluctance

11 Jun 2024

Read more

Deals

Eight Advisory supported Holnest on the acquisition of LDLC Arena from OL Group

11 Jun 2024

Read more

Deals

Eight Advisory supported Talan Group in the context of its takeover bid for Micropole Group

7 Jun 2024

Read more

Corporate News

Eight Advisory supported BSI Business Systems Integration AG on the acquisition of riskine GmbH

5 Jun 2024

Read more

All the news

Your message has been sent
Thank you, your application has been sent.

What is the subject of your request?

  • General questions
  • Jobs
  • Information for the press

Specify your request

Choose an office

  • Eight Advisory London

  • Eight Advisory Paris

  • Eight Advisory Rennes

  • Eight Advisory Nantes

  • Eight Advisory Lyon

  • Eight Advisory Marseille

  • Eight Advisory Brussels

  • Eight Advisory Frankfurt

  • Eight Advisory Munich

  • Eight Advisory Hamburg

  • Eight Advisory Zurich

  • Eight Advisory Amsterdam

  • Eight Advisory Cologne

  • Eight Advisory Madrid

  • Eight Advisory New York

Application

Unsolicited application

Specify your request